# ImmunityBio, Inc. (IBRX) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$256M |
| 2024 | -$344M |
| 2023 | -$362M |
| 2022 | -$351M |
| 2021 | -$330M |
| 2020 | -$221M |
| 2019 | -$156M |
| 2018 | -$98M |
| 2017 | -$99M |
| 2016 | -$125M |
| 2015 | -$239M |
| 2014 | -$6M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$70M |
| 2025-09-30 | -$56M |
| 2025-06-30 | -$71M |
| 2025-03-31 | -$64M |
| 2024-09-30 | -$80M |
| 2024-06-30 | -$99M |
| 2024-03-31 | -$95M |
| 2023-09-30 | -$80M |
| 2023-06-30 | -$85M |
| 2023-03-31 | -$112M |
| 2022-09-30 | -$91M |
| 2022-06-30 | -$80M |
| 2022-03-31 | -$96M |
| 2021-09-30 | -$79M |
| 2021-06-30 | -$86M |
| 2021-03-31 | -$86M |
| 2020-09-30 | -$66M |
| 2020-06-30 | -$51M |
| 2020-03-31 | -$37M |
| 2019-09-30 | -$16M |
| 2019-06-30 | -$17M |
| 2019-03-31 | -$18M |
| 2018-09-30 | -$24M |
| 2018-06-30 | -$28M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/IBRX/operating-income)